Companies: 10,795·Total market cap: $144.5T
InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc.

INMNASDAQHealthcare● Active
$1.50
$-0.08(-5.06%)
Market Cap$2714889
P/E Ratio
52W High$5.5
52W Low$0.575
Overview

InMed Pharmaceuticals Inc. (INM) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · INM · as of Sep 23, 2025

Latest filing snapshot

13
+0+0.00%vs prior year

InMed Pharmaceuticals Inc. (INM) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-06-30·Full-time · Global
Total Employees
13
Change (1Y)
+0
Growth % (1Y)
+0.00%
Revenue / Employee
$380.2K
Net Income / Employee
$-627.9K
Market Cap
$3M

INM Employee Count

2021 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-09-2313+0+0.00%
2024-09-3013+0+0.00%
2023-09-2913+0+0.00%
2022-09-2313+1+8.33%
2021-09-2412

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Genprex, Inc.
GNPX
Genprex, Inc.
15
#2
BioVie Inc.
BIVI
BioVie Inc.
14
#3
InMed Pharmaceuticals Inc.
INM
InMed Pharmaceuticals Inc.YOU
13
#4
Biodexa Pharmaceuticals Plc
BDRX
Biodexa Pharmaceuticals Plc
13
#5
CNS Pharmaceuticals, Inc.
CNSP
CNS Pharmaceuticals, Inc.
4
#6
Estrella Immunopharma, Inc.
ESLA
Estrella Immunopharma, Inc.
3
#7
Galmed Pharmaceuticals Ltd.
GLMD
Galmed Pharmaceuticals Ltd.
3
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · INM peer comparison

About INM employees

INM Employees · Headcount

InMed Pharmaceuticals Inc. (INM) employee data is sourced from the annual SEC 10-K filing. As of 2025, InMed Pharmaceuticals Inc. had 13 full-time employees globally. Full-time employees only. Global consolidated headcount.

InMed Pharmaceuticals Inc. employs 13 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $380,203, reflecting the company's operational efficiency.

InMed Pharmaceuticals Inc.'s workforce increased by 0 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

InMed Pharmaceuticals Inc.'s revenue per employee of $380,203 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

INM Employees · 5 questions

As of the latest SEC 10-K filing (2025), InMed Pharmaceuticals Inc. had 13 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

InMed Pharmaceuticals Inc. employee counthow many employees does InMed Pharmaceuticals Inc. haveINM total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-09-23